Finalizes $9.9M Offering at Premium to Recent Trading Price Amidst Nasdaq Delisting Threat

summarizeSummary

TIAN RUIXIANG Holdings Ltd. finalized a highly dilutive offering of up to $9.9 million in shares and warrants at a premium to its recent trading price, providing critical capital as the company faces a Nasdaq delisting notice.

check_boxKey Events

• Finalizes Capital Raise

  The company is offering 7,200,000 Class A Ordinary Shares and an option for investors to purchase up to an additional 72,000,000 Class A Ordinary Shares or Pre-Funded Warrants, with an expected initial closing on February 4, 2026.

• Significant Proceeds and Dilution

  The offering is expected to generate approximately $0.7 million in net proceeds initially, increasing to $9.0 million if the option for additional shares is fully exercised. This represents a potential dilution of over 100% to existing shareholders.

• Premium Pricing to Recent Market

  The offering price is set at $0.125 per share, which is a significant premium compared to the last reported sale price of $0.0756 per share on February 2, 2026, as stated in the filing.

• Addresses Nasdaq Delisting Threat

  This capital raise provides crucial funding for the company, which received a Nasdaq delisting notice on January 20, 2026, for failing to meet the minimum bid price requirement. A hearing is scheduled for February 17, 2026.

auto_awesomeAnalysis

TIAN RUIXIANG Holdings Ltd. has finalized a substantial capital raise, offering up to 79.2 million Class A Ordinary Shares and Pre-Funded Warrants, which could generate up to $9.0 million in net proceeds. This offering is critical for the nano-cap company, especially as it faces a Nasdaq delisting notice for failing to meet the minimum bid price requirement. The offering price of $0.125 per share is notably at a premium to the last reported sale price of $0.0756 on February 2, 2026, indicating institutional confidence despite the company's distressed situation. However, the potential for over 100% dilution (79.2 million new shares on 74.2 million existing shares) is extremely significant and will heavily impact existing shareholders. The proceeds are earmarked for working capital and general corporate purposes, providing a crucial lifeline to address immediate operational needs and the delisting challenge.